@ShahidNShah
Case study: Reducing readmission rates via interactive patient screenings
Like all hospitals, McLaren Port Huron in Michigan is constantly searching for ways to reduce our readmission rates. No small task, considering that one of every six discharged patients in the United States is readmitted in fewer than 30 days, and a third of those within only seven days of discharge, according to a March 2019 article from Forbes.
As McLaren’s clinical outcomes coordinator, I’ve done a lot of research over the years to discover the best way to do this. And everything I’ve read points to one thing – readmissions can be largely attributed to what happens after the patient leaves our care. Even with a team of the most dedicated physicians, nurses, and other clinicians, we can only do so much to address factors such as healthy eating, medication adherence and the availability of transportation to follow-up appointments after the patient is discharged. And it’s precisely these factors – all impacted by larger social determinants of health (SDOH) to one degree or another – that influence whether (and how soon) our inpatients become readmission statistics.
In fact, a report from the Yale Global Health Leadership Institute notes that actual medical care only makes up 20% of what determines a patient’s health; the rest is determined by genetics (20%) and the majority by social, environmental and behavioral factors (60%).
Continue reading at healthcarebusinesstech.com
Make faster decisions with community advice
- FDA Orange Book Express 2.0
- Patient handoffs to post-acute care providers still largely a manual process, hindering effective c…
- Report: Most Health Systems Still Lack Long-Term Digital Strategy
- Hundreds of exposed Amazon cloud backups found leaking sensitive data
- Wide Variety of Groups Support Standardizing Addresses in Electronic Health Records
Next Article
-
FDA Orange Book Express 2.0
The Food and Drug Administration (FDA) Orange Book is now in its 39th edition. The information in the book stems from the requirement of the FDA to provide states information regarding pharmaceutical …
Posted Aug 16, 2019fda